Current glaucoma therapy is primarily focused on the reduction in intraocular pressure by medical therapy, laser or surgical means. Hardly any other clinical centre devoted to glaucoma research has contributed so much to our knowledge of the cellular pathomechanisms that lead to glaucomatous damage like the role of ocular blood flow, vascular dysregulations and the impact of free radicals as the University Eye Hospital in Basel, …